Try our Advanced Search for more refined results

Expert Analysis

FDA's Stepwise Approach To Demonstrating Biosimilarity

Law360, New York (February 10, 2012, 5:22 PM EST) -- On Feb. 9, the U.S. Food and Drug Administration issued the agency's first set of draft guidance documents outlining the framework for how it will evaluate applications for regulatory approval of biosimilar products. The long-awaited guidance provide the first detailed comments from FDA on the topic....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!